Campbell & Co Investment Adviser’s Astrana Health ASTH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,963	Closed	-$367K	–	1404
2026 Q1	$367K	Buy	+14,963	New	+$354K	0.02%	832
2025 Q4	–	Sell	-40,705	Closed	-$1.15M	–	1461
2025 Q3	$1.15M	Buy	+40,705	New	+$1.1M	0.09%	360
2025 Q1	–	Sell	-56,348	Closed	-$1.78M	–	1396
2024 Q4	$1.78M	Buy	56,348 +46,699	+484%	+$2.22M	0.14%	211
2024 Q3	$559K	Buy	9,649 +1,294	+15%	+$63.6K	0.04%	668
2024 Q2	$339K	Buy	8,355 +1,058	+14%	+$42K	0.03%	794
2024 Q1	$306K	Sell	7,297 -20,552	-74%	-$802K	0.03%	896
2023 Q4	$1.07M	Buy	+27,849	New	+$927K	0.1%	359

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return

Campbell & Co Investment Adviser's ASTH Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 14,963 shares — an estimated $367K sold.

Campbell & Co Investment Adviser first reported a position in ASTH in Q4 2023 and held it in 7 quarters. The position peaked at $1.78M in Q4 2024. 73 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Campbell & Co Investment Adviser reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
Campbell & Co Investment Adviser sold 14,963 Astrana Health shares in Q2 2026, an estimated $367K.
Campbell & Co Investment Adviser first reported a position in Astrana Health in Q4 2023 and held it in 7 quarters.
Campbell & Co Investment Adviser's Astrana Health position peaked at $1.78M in Q4 2024.
73 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.